PLoS ONE (Jan 2022)

Effectiveness of shengxuexiaoban capsules combined with glucocorticoid therapy for immune thrombocytopenia: A meta-analysis.

  • Meng-Yuan Ding,
  • Bing Li,
  • Meng Yang,
  • Wen-Sheng Zhai,
  • Chun-Dong Song,
  • Jian Zhang,
  • Qiu-Yue Zhang,
  • Peng-Fei Li,
  • Li-Ya Liu

DOI
https://doi.org/10.1371/journal.pone.0275122
Journal volume & issue
Vol. 17, no. 9
p. e0275122

Abstract

Read online

ObjectiveTo evaluate the effectiveness of the Shengxuexiaoban Capsules combined with glucocorticoid therapy for immune thrombocytopenia (ITP).MethodsWe collected randomized controlled trials (RCTs) using shengxuexiaoban capsules in combination with glucocorticoid to treat ITP by searching major Chinese and English electronic databases. The outcome indicators were the effective rate, recurrence rate, the number of platelets in the blood, recovery time of platelets, and adverse reactions. We used STATA 16.0 and RevMan 5.3 for meta-analysis and GRADE pro. for evidence quality evaluation.ResultsA total of 27 RCTs were included in the meta-analysis, and the results showed a significant difference (all pConclusionGlucocorticoid therapy combined with the Shengxuexiaoban Capsules showed more effectiveness in the treatment of ITP. It can improve the effective rate, reduce the recurrence rate, increase the number of platelets and shorten the recovery time of platelets, and has a good safety profile.